The increased levels of inflammatory chemokines in ICU COVID-19 patients and the role of NF-κB in SARS-CoV-2 infection are well-documented [30–32], as is the involvement of TGF-β in pulmonary fibrosis caused by COVID-19 [33]. Here, TGFB1 is linked to pulmonary fibrosis.